Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 587

1.

Exploring rare and low-frequency variants in the Saguenay-Lac-Saint-Jean population identified genes associated with asthma and allergy traits.

Morin A, Madore AM, Kwan T, Ban M, Partanen J, Rönnblom L, Syvänen AC, Sawcer S, Stunnenberg H, Lathrop M, Pastinen T, Laprise C.

Eur J Hum Genet. 2018 Sep 11. doi: 10.1038/s41431-018-0266-4. [Epub ahead of print]

PMID:
30206357
2.

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation.

Ritari J, Hyvärinen K, Koskela S, Itälä-Remes M, Niittyvuopio R, Nihtinen A, Salmenniemi U, Putkonen M, Volin L, Kwan T, Pastinen T, Partanen J.

Leukemia. 2018 Aug 8. doi: 10.1038/s41375-018-0229-3. [Epub ahead of print]

PMID:
30089915
3.

Lifetime Measurements of Excited States in ^{172}Pt and the Variation of Quadrupole Transition Strength with Angular Momentum.

Cederwall B, Doncel M, Aktas Ö, Ertoprak A, Liotta R, Qi C, Grahn T, Cullen DM, Hodge D, Giles M, Stolze S, Badran H, Braunroth T, Calverley T, Cox DM, Fang YD, Greenlees PT, Hilton J, Ideguchi E, Julin R, Juutinen S, Raju MK, Li H, Liu H, Matta S, Modamio V, Pakarinen J, Papadakis P, Partanen J, Petrache CM, Rahkila P, Ruotsalainen P, Sandzelius M, Sarén J, Scholey C, Sorri J, Subramaniam P, Taylor MJ, Uusitalo J, Valiente-Dobón JJ.

Phys Rev Lett. 2018 Jul 13;121(2):022502. doi: 10.1103/PhysRevLett.121.022502.

PMID:
30085703
4.

Implementation of Industrial Additive Manufacturing: Intelligent Implants and Drug Delivery Systems.

Akmal JS, Salmi M, Mäkitie A, Björkstrand R, Partanen J.

J Funct Biomater. 2018 Jun 29;9(3). pii: E41. doi: 10.3390/jfb9030041.

5.

Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation.

Koskela S, Ritari J, Hyvärinen K, Kwan T, Niittyvuopio R, Itälä-Remes M, Pastinen T, Partanen J.

Sci Rep. 2018 Mar 29;8(1):5396. doi: 10.1038/s41598-018-23682-y.

6.

Blood donors' preferences for blood donation for biomedical research.

Raivola V, Snell K, Pastila S, Helén I, Partanen J.

Transfusion. 2018 Jul;58(7):1640-1646. doi: 10.1111/trf.14596. Epub 2018 Mar 23.

PMID:
29572859
7.

Discrimination hurts: The effect of discrimination on the development of chronic pain.

Brown TT, Partanen J, Chuong L, Villaverde V, Chantal Griffin A, Mendelson A.

Soc Sci Med. 2018 May;204:1-8. doi: 10.1016/j.socscimed.2018.03.015. Epub 2018 Mar 8.

PMID:
29549869
8.

Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.

Keto J, Kaartinen T, Salmenniemi U, Castrén J, Partanen J, Hänninen A, Korhonen M, Lähteenmäki K, Itälä-Remes M, Nystedt J.

Mol Ther Methods Clin Dev. 2018 Feb 8;9:109-118. doi: 10.1016/j.omtm.2018.02.001. eCollection 2018 Jun 15.

9.

Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool.

Zega K, Jovanovic VM, Vitic Z, Niedzielska M, Knaapi L, Jukic MM, Partanen J, Friedel RH, Lang R, Brodski C.

Front Mol Neurosci. 2018 Feb 1;11:29. doi: 10.3389/fnmol.2018.00029. eCollection 2018.

10.

Accuracy of Programs for the Determination of Human Leukocyte Antigen Alleles from Next-Generation Sequencing Data.

Larjo A, Eveleigh R, Kilpeläinen E, Kwan T, Pastinen T, Koskela S, Partanen J.

Front Immunol. 2017 Dec 13;8:1815. doi: 10.3389/fimmu.2017.01815. eCollection 2017.

11.

Retrospective analysis of capillary hemoglobin recovery in nearly 1 200 000 blood donor returns.

Niittymäki P, Arvas M, Larjo A, Mattila P, Ihalainen J, Syrjälä M, Castrén J, Partanen J.

Blood Adv. 2017 Jun 8;1(14):961-967. doi: 10.1182/bloodadvances.2016004218. eCollection 2017 Jun 13.

12.

Applications of genomic medicine in the treatment of diseases.

Porkka K, Niemi M, Leppä E, Västrik I, Partanen J, Ihalainen J, Jokiranta S, Pöllänen P.

Duodecim. 2017;133(8):782-90. Review.

PMID:
29240345
13.

Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool.

Zega K, Jovanovic VM, Vitic Z, Niedzielska M, Knaapi L, Jukic MM, Partanen J, Friedel RH, Lang R, Brodski C.

Front Mol Neurosci. 2017 Nov 9;10:372. doi: 10.3389/fnmol.2017.00372. eCollection 2017. Erratum in: Front Mol Neurosci. 2018 Feb 01;11:29.

14.

Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease.

Hyvärinen K, Ritari J, Koskela S, Niittyvuopio R, Nihtinen A, Volin L, Gallardo D, Partanen J.

Sci Rep. 2017 Nov 15;7(1):15666. doi: 10.1038/s41598-017-15915-3.

15.

A complex genomic locus drives mtDNA replicase POLG expression to its disease-related nervous system regions.

Nikkanen J, Landoni JC, Balboa D, Haugas M, Partanen J, Paetau A, Isohanni P, Brilhante V, Suomalainen A.

EMBO Mol Med. 2018 Jan;10(1):13-21. doi: 10.15252/emmm.201707993.

16.

Melanoblast development coincides with the late emerging cells from the dorsal neural tube in turtle Trachemys scripta.

Rice R, Cebra-Thomas J, Haugas M, Partanen J, Rice DPC, Gilbert SF.

Sci Rep. 2017 Sep 21;7(1):12063. doi: 10.1038/s41598-017-12352-0.

17.

Nanofibrillar cellulose-alginate hydrogel coated surgical sutures as cell-carrier systems.

Laurén P, Somersalo P, Pitkänen I, Lou YR, Urtti A, Partanen J, Seppälä J, Madetoja M, Laaksonen T, Mäkitie A, Yliperttula M.

PLoS One. 2017 Aug 22;12(8):e0183487. doi: 10.1371/journal.pone.0183487. eCollection 2017.

18.

Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients.

Lähteenmäki K, Wacklin P, Taskinen M, Tuovinen E, Lohi O, Partanen J, Mättö J, Vettenranta K.

Bone Marrow Transplant. 2017 Oct;52(10):1479-1482. doi: 10.1038/bmt.2017.168. Epub 2017 Aug 7. No abstract available.

PMID:
28783141
19.

Altered N100-potential associates with working memory impairment in Parkinson's disease.

Annanmaki T, Palmu K, Murros K, Partanen J.

J Neural Transm (Vienna). 2017 Oct;124(10):1197-1203. doi: 10.1007/s00702-017-1758-z. Epub 2017 Jul 14.

PMID:
28710524
20.

NETO1 Guides Development of Glutamatergic Connectivity in the Hippocampus by Regulating Axonal Kainate Receptors.

Orav E, Atanasova T, Shintyapina A, Kesaf S, Kokko M, Partanen J, Taira T, Lauri SE.

eNeuro. 2017 Jul 3;4(3). pii: ENEURO.0048-17.2017. doi: 10.1523/ENEURO.0048-17.2017. eCollection 2017 May-Jun.

21.

Three cases of acute distal demyelinating neuropathy with recovery.

Österlund-Tauriala E, Partanen JV.

Clin Case Rep. 2017 Apr 17;5(6):822-828. doi: 10.1002/ccr3.943. eCollection 2017 Jun.

22.

A rare type of fibrillation-like EMG activity.

Partanen JV.

Clin Neurophysiol Pract. 2017 Mar 6;2:65-66. doi: 10.1016/j.cnp.2017.02.003. eCollection 2017. No abstract available.

23.

Correction: B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study.

Kantola K, Hedman L, Tanner L, Simell V, Mäkinen M, Partanen J, Sadeghi M, Veijola R, Knip M, Ilonen J, Hyöty H, Toppari J, Simell O, Hedman K, Söderlund-Venermo M.

PLoS One. 2017 Feb 8;12(2):e0172078. doi: 10.1371/journal.pone.0172078. eCollection 2017.

24.

Tectal-derived interneurons contribute to phasic and tonic inhibition in the visual thalamus.

Jager P, Ye Z, Yu X, Zagoraiou L, Prekop HT, Partanen J, Jessell TM, Wisden W, Brickley SG, Delogu A.

Nat Commun. 2016 Dec 8;7:13579. doi: 10.1038/ncomms13579.

25.

Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML.

Impola U, Larjo A, Salmenniemi U, Putkonen M, Itälä-Remes M, Partanen J.

Front Immunol. 2016 Nov 21;7:523. eCollection 2016.

26.

Gata2 and Gata3 regulate the differentiation of serotonergic and glutamatergic neuron subtypes of the dorsal raphe.

Haugas M, Tikker L, Achim K, Salminen M, Partanen J.

Development. 2016 Dec 1;143(23):4495-4508. Epub 2016 Oct 27.

27.

Epileptic Electroencephalography Profile Associates with Attention Problems in Children with Fragile X Syndrome: Review and Case Series.

Cowley B, Kirjanen S, Partanen J, Castrén ML.

Front Hum Neurosci. 2016 Jul 12;10:353. doi: 10.3389/fnhum.2016.00353. eCollection 2016.

28.

A recessive syndrome of intellectual disability, moderate overgrowth, and renal dysplasia predisposing to Wilms tumor is caused by a mutation in FIBP gene.

Akawi N, Ben-Salem S, Lahti L, Partanen J, Ali BR, Al-Gazali L.

Am J Med Genet A. 2016 Aug;170(8):2111-8. doi: 10.1002/ajmg.a.37741. Epub 2016 May 17. Review.

PMID:
27183861
29.

In vitro Treg expansion favors the full-length splicing isoform of CTLA4.

Kaartinen T, Harjunpää H, Partanen J, Tiittanen M.

Immunotherapy. 2016 May;8(5):541-53. doi: 10.2217/imt.16.7.

PMID:
27140408
30.

Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.

Sonneveld ME, Natunen S, Sainio S, Koeleman CA, Holst S, Dekkers G, Koelewijn J, Partanen J, van der Schoot CE, Wuhrer M, Vidarsson G.

Br J Haematol. 2016 Jul;174(2):310-20. doi: 10.1111/bjh.14053. Epub 2016 Mar 28.

PMID:
27017954
31.

Optimal digital filters for analyzing the mid-latency auditory P50 event-related potential in patients with Alzheimer's disease.

Liljander S, Holm A, Keski-Säntti P, Partanen JV.

J Neurosci Methods. 2016 Jun 15;266:50-67. doi: 10.1016/j.jneumeth.2016.03.013. Epub 2016 Mar 22.

PMID:
27015794
32.

Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.

Linjama T, Impola U, Niittyvuopio R, Kuittinen O, Kaare A, Rimpiläinen J, Volin L, Peräsaari J, Jaatinen T, Lauronen J, Saarinen T, Juvonen E, Partanen J, Koskela S.

HLA. 2016 May;87(5):350-5. doi: 10.1111/tan.12770. Epub 2016 Mar 10.

PMID:
26969202
33.

Ephaptic transmission from type ii afferents to static γ and β efferents causes complex repetitive discharge: An hypothesis.

Partanen JV.

Muscle Nerve. 2016 Apr;53(4):508-12. doi: 10.1002/mus.25056. Epub 2016 Feb 26.

PMID:
26802675
34.

Human stem cell decorated nanocellulose threads for biomedical applications.

Mertaniemi H, Escobedo-Lucea C, Sanz-Garcia A, Gandía C, Mäkitie A, Partanen J, Ikkala O, Yliperttula M.

Biomaterials. 2016 Mar;82:208-20. doi: 10.1016/j.biomaterials.2015.12.020. Epub 2015 Dec 21.

PMID:
26763735
35.

Differentiation and molecular heterogeneity of inhibitory and excitatory neurons associated with midbrain dopaminergic nuclei.

Lahti L, Haugas M, Tikker L, Airavaara M, Voutilainen MH, Anttila J, Kumar S, Inkinen C, Salminen M, Partanen J.

Development. 2016 Feb 1;143(3):516-29. doi: 10.1242/dev.129957. Epub 2015 Dec 30.

36.

Myotonia in ion channel diseases of muscle.

Partanen J, Isohanni P, Auranen M.

Duodecim. 2016;132(19):1810-4.

PMID:
29188980
37.

Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress.

Ylikallio E, Konovalova S, Dhungana Y, Hilander T, Junna N, Partanen JV, Toppila JP, Auranen M, Tyynismaa H.

BBA Clin. 2015 Mar 11;3:233-42. doi: 10.1016/j.bbacli.2015.03.002. eCollection 2015 Jun.

38.

Diversity and development of local inhibitory and excitatory neurons associated with dopaminergic nuclei.

Morello F, Partanen J.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3693-701. doi: 10.1016/j.febslet.2015.10.001. Epub 2015 Oct 20. Review.

39.

B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study.

Kantola K, Hedman L, Tanner L, Simell V, Mäkinen M, Partanen J, Sadeghi M, Veijola R, Knip M, Ilonen J, Hyöty H, Toppari J, Simell O, Hedman K, Söderlund-Venermo M.

PLoS One. 2015 Sep 29;10(9):e0139096. doi: 10.1371/journal.pone.0139096. eCollection 2015. Erratum in: PLoS One. 2017 Feb 8;12 (2):e0172078.

40.

Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation.

Myant K, Qiao X, Halonen T, Come C, Laine A, Janghorban M, Partanen JI, Cassidy J, Ogg EL, Cammareri P, Laiterä T, Okkeri J, Klefström J, Sears RC, Sansom OJ, Westermarck J.

Cell Rep. 2015 Aug 11;12(6):1019-31. doi: 10.1016/j.celrep.2015.07.003. Epub 2015 Jul 30.

41.

Adapting Phonological Awareness Interventions for Children With Down Syndrome Based on the Behavioral Phenotype: A Promising Approach?

Lemons CJ, King SA, Davidson KA, Puranik CS, Fulmer D, Mrachko AA, Partanen J, Al Otaiba S, Fidler DJ.

Intellect Dev Disabil. 2015 Aug;53(4):271-88. doi: 10.1352/1934-9556-53.4.271.

PMID:
26214557
42.

Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients.

Impola U, Turpeinen H, Alakulppi N, Linjama T, Volin L, Niittyvuopio R, Partanen J, Koskela S.

Front Immunol. 2014 Aug 25;5:405. doi: 10.3389/fimmu.2014.00405. eCollection 2014.

43.

Internal development of vegetative buds of Norway spruce trees in relation to accumulated chilling and forcing temperatures.

Viherä-Aarnio A, Sutinen S, Partanen J, Häkkinen R.

Tree Physiol. 2014 May;34(5):547-56. doi: 10.1093/treephys/tpu038. Epub 2014 May 29.

PMID:
24876293
44.

Medium-high resolution electrochemical genotyping of HLA-DQ2/DQ8 for detection of predisposition to coeliac disease.

Joda H, Beni V, Alakulppi N, Partanen J, Lind K, Strömbom L, Latta D, Höth J, Katakis I, O'Sullivan CK.

Anal Bioanal Chem. 2014 May;406(12):2757-69. doi: 10.1007/s00216-014-7650-x. Epub 2014 Mar 15.

PMID:
24633503
45.

Interaction with intestinal epithelial cells promotes an immunosuppressive phenotype in Lactobacillus casei.

Tiittanen M, Keto J, Haiko J, Mättö J, Partanen J, Lähteenmäki K.

PLoS One. 2013 Nov 7;8(11):e78420. doi: 10.1371/journal.pone.0078420. eCollection 2013.

46.

Mechanisms regulating GABAergic neuron development.

Achim K, Salminen M, Partanen J.

Cell Mol Life Sci. 2014 Apr;71(8):1395-415. doi: 10.1007/s00018-013-1501-3. Epub 2013 Nov 7. Review.

PMID:
24196748
47.

The role of Tal2 and Tal1 in the differentiation of midbrain GABAergic neuron precursors.

Achim K, Peltopuro P, Lahti L, Tsai HH, Zachariah A, Astrand M, Salminen M, Rowitch D, Partanen J.

Biol Open. 2013 Aug 9;2(10):990-7. doi: 10.1242/bio.20135041. eCollection 2013.

48.

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Khanna A, Kauko O, Böckelman C, Laine A, Schreck I, Partanen JI, Szwajda A, Bormann S, Bilgen T, Helenius M, Pokharel YR, Pimanda J, Russel MR, Haglund C, Cole KA, Klefström J, Aittokallio T, Weiss C, Ristimäki A, Visakorpi T, Westermarck J.

Cancer Res. 2013 Nov 15;73(22):6757-69. doi: 10.1158/0008-5472.CAN-13-1002. Epub 2013 Sep 26.

49.

Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4.

Partanen JI, Tervonen TA, Klefström J.

Philos Trans R Soc Lond B Biol Sci. 2013 Sep 23;368(1629):20130111. doi: 10.1098/rstb.2013.0111. Print 2013. Review.

50.

Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A, Oudshoorn M, Loiseau P, Dolstra H, Markiewicz M, Leffell MS, Pereira N, Kircher B, Turpeinen H, Eliaou JF, Gervais T, Laurin D, Enczmann J, Martinetti M, Thomson J, Oguz F, Santarone S, Partanen J, Siekiera U, Alessandrino EP, Kalayoglu S, Brand R, Goulmy E.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.

Supplemental Content

Loading ...
Support Center